Proliferative Vitreoretinopathy Clinical Trial
Verified date | July 2007 |
Source | hahid Beheshti University of Medical Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ethics Committee |
Study type | Interventional |
To evaluate the effect of combined 5-FU and low molecular weight heparin in infusion on the rate of retinal redetachment after silicone oil removal in cases of proliferative vitreoretinopathy (PVR).
Status | Active, not recruiting |
Enrollment | 0 |
Est. completion date | July 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Cases with history of vitrectomy and silicone oil injection for management of PVR who undergo silicone oil removal Exclusion Criteria: - any sign of retinal redetachment before silicone oil removal - any sign of diabetic retinopathy |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Hamid Ahmadieh, MD | Tehran |
Lead Sponsor | Collaborator |
---|---|
hahid Beheshti University of Medical Sciences |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Retinal redetachment rate | |||
Secondary | visual acuity | |||
Secondary | intraocular pressure | |||
Secondary | reoperation | |||
Secondary | relative afferent pupillary defect |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05561569 -
Air Versus Gas Tamponade in Primary Retinal Detachment
|
N/A | |
Not yet recruiting |
NCT05538156 -
Internal Limiting Membrane Peeling in Retinal Detachment Surgery
|
N/A | |
Completed |
NCT01445028 -
Isotretinoin for Proliferative Vitreoretinopathy
|
Phase 4 | |
Recruiting |
NCT00370760 -
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
|
Phase 3 | |
Completed |
NCT00000140 -
The Silicone Study
|
Phase 3 | |
Completed |
NCT06166914 -
Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
|
N/A | |
Recruiting |
NCT04580147 -
Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
|
Phase 2 | |
Completed |
NCT04891991 -
Intravitreal Infliximab for Proliferative Vitreoretinopathy
|
Phase 2 | |
Completed |
NCT01255293 -
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
|
N/A | |
Completed |
NCT04136366 -
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
|
Phase 3 | |
Recruiting |
NCT06289205 -
"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"
|
Phase 1/Phase 2 | |
Completed |
NCT00373282 -
Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy
|
Phase 3 | |
Completed |
NCT01995045 -
Postoperative Pain Control Following Vitreoretinal Surgery
|
Phase 4 | |
Completed |
NCT04490876 -
Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoretinopathy
|
||
Not yet recruiting |
NCT06425419 -
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
|
Phase 1 | |
Completed |
NCT02192970 -
Bevacizumab Against Recurrent Retinal Detachment
|
Phase 2 | |
Not yet recruiting |
NCT04682054 -
Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics
|
N/A | |
Recruiting |
NCT05660447 -
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06033703 -
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
|
Phase 1/Phase 2 | |
Completed |
NCT03727776 -
Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
|
Early Phase 1 |